Healthcare Latest news, Medical Technology Updated News
HIGHLIGHTS EU and Italy are no longer exporting Astrazeneca vaccine to Australia. Europe is citing shortage of vaccine to justify refusal to export. The export of a shipment of more than a quarter million AstraZeneca vaccines destined for Australia has…
HIGHLIGHTS France is distributing the AstraZeneca’s COVID-19 vaccine. As epidemiologist Arnaud Fontanet warned about possibility of coronavirus variant B.1.1.7 from UK dominating Franceby MAR 2021. France has started distributing the AstraZeneca’s COVID-19 vaccine as epidemiologist Arnaud Fontanet warned the government…
HIGHLIGHTS AstraZeneca and Care Access Research have forged a partnership to support the Phase III clinical trial for AZD7442. AZD7442 has been developed by AstraZeneca as an attempt to prevent COVID-19. AZD7442 is a monoclonal antibody combination. Participants for this…
Highlights – EU authorizes AstraZeneca’s COVID-19 vaccine for adults throughout 27 nations. The European Medicines Agency unanimously recommended the vaccine to be used. The vaccine is said to be 60% effective, in comparison to Pfizer and Moderna’s vaccine. The vaccine…
The British-Swedish pharma giant AstraZeneca (AZ) has decided to sublicense its global rights to Movantik (naloxegol) to RedHill Biopharma. However, AZ has said that it will continue to manufacture and supply the chronic non-cancer pain drug to RedHill during a…
AstraZeneca has confirmed that budesonide / glycopyrronium / formoterol fumarate has been approved for chronic obstructive pulmonary disease (COPD) rehabilitation treatment in China. This is the National Medical Products Administration’s first certification for a triple-combination therapy in a pressurized metered-dose…
The primary yearly Pharmaceutical Invention Index, discharged by IDEA Pharma today, sees AstraZeneca top the business for the curiosity and broadness of its pipeline. Discharged without precedent for 2019, at the Pharma Innovation Summit in Boca Raton, FL, the Pharmaceutical…
Japan’s Shionogi and Co Ltd <4507.T> has played safe when selling its medications in the United States and different abroad markets – depending on greater accomplices to advance its items and evading the expense of keeping up an enormous deals…
According to the results of phase III clinical trial, by the addition of Imfinzi to the standard first-line chemotherapy resulted in the clinically meaningful extension in the overall survival rate of the patients who have advanced small cell lung cancer…